Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 200 Total
TFFP - Tff Pharmaceuticals Inc - Stock Price Chart
TickerTFFP [NASD]
CompanyTff Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.70MEPS (ttm)-10.21
P/E-EPS this Y60.34%
Forward P/E-EPS next Y17.23%
PEG-EPS past 5Y-13.86%
P/S-EPS next 5Y-
P/B1.03EPS Q/Q50.69%
Dividend-Sales Q/Q-
Insider Own7.13%Inst Own11.45%
Insider Trans0.00%Inst Trans9.61%
Short Float4.30%EarningsMay 14/a
Analyst Recom1.00Target Price24.50
Avg Volume39.21K52W Range1.54 - 17.02
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARLSON CAPITAL L P10% OwnerAug 16 '23Sale0.391,0003925,064,000Aug 17 05:29 PM
Weisman Harlan FPresident and CEOAug 15 '23Buy0.25600,000150,000814,615Aug 15 08:00 AM
Mikhak ZamanehChief Medical OfficerAug 15 '23Buy0.25120,00030,000135,000Aug 15 08:00 AM
MILLS ROBERT SDirectorAug 15 '23Buy0.2540,00010,00055,980Aug 15 08:00 AM
ROCAMBOLI STEPHENDirectorAug 15 '23Buy0.2520,0005,00036,000Aug 15 08:00 AM
GDS - GDS Holdings Limited ADR - Stock Price Chart
TickerGDS [NASD]
CompanyGDS Holdings Limited ADR
CountryChina
IndustryInformation Technology Services
Market Cap1.74BEPS (ttm)-3.30
P/E-EPS this Y-171.90%
Forward P/E-EPS next Y32.60%
PEG-EPS past 5Y-44.77%
P/S1.24EPS next 5Y0.51%
P/B0.64EPS Q/Q-1506.64%
Dividend-Sales Q/Q4.69%
Insider Own7.02%Inst Own25.50%
Insider Trans0.00%Inst Trans-11.66%
Short Float7.08%EarningsMay 22/b
Analyst Recom1.31Target Price15.17
Avg Volume1.71M52W Range5.01 - 14.24
GDS Holdings Ltd. engages in developing and operating data centers in China. It builds, operates, and transfers data centers at other locations. Its data centers are carrier and cloud-neutral, which enable customers to connect to major telecommunications carriers, and to access a number of cloud service providers. The firm also offers colocation and managed services, which include direct private connection to major public cloud platforms. The company was founded by William Wei Huang in 2001 and is headquartered in Pudong, China.
DOGZ - Dogness (International) Corp - Stock Price Chart
TickerDOGZ [NASD]
CompanyDogness (International) Corp
CountryChina
IndustryLeisure
Market Cap88.60MEPS (ttm)-0.41
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6.39EPS next 5Y-
P/B1.17EPS Q/Q-300.13%
Dividend-Sales Q/Q-35.81%
Insider Own84.73%Inst Own0.22%
Insider Trans0.00%Inst Trans7.09%
Short Float1.30%Earnings-
Analyst Recom-Target Price-
Avg Volume213.70K52W Range2.79 - 18.40
Dogness (International) Corp. engages in the design and manufacture of pet products, including leashes, and smart products. Its products include leashes, lanyards, ribbon, collars, harnesses ornaments, and specialty products for cats and dogs. The firm produces the products in Classic, Elegance, Luxury, LED, Holiday, Special Function, and Cat series. The company was founded by Shilong Chen in 2003 and is headquartered in Dongguan, China.
MORF - Morphic Holding Inc - Stock Price Chart
TickerMORF [NASD, RUT]
CompanyMorphic Holding Inc
CountryUSA
IndustryBiotechnology
Market Cap1.63BEPS (ttm)-3.38
P/E-EPS this Y-9.58%
Forward P/E-EPS next Y-9.68%
PEG-EPS past 5Y-35.64%
P/S-EPS next 5Y-
P/B2.45EPS Q/Q-0.54%
Dividend-Sales Q/Q-100.00%
Insider Own22.78%Inst Own88.62%
Insider Trans-0.31%Inst Trans-1.45%
Short Float16.59%EarningsApr 25/b
Analyst Recom1.40Target Price56.00
Avg Volume414.11K52W Range19.34 - 63.08
Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rogers BrucePRESIDENTMar 27 '24Option Exercise4.327,40031,932149,883Mar 28 07:00 PM
Tipirneni Praveen P.CEOJan 16 '24Sale27.4913,923382,75342,013Jan 17 07:04 PM
Rogers BrucePresidentJan 16 '24Sale27.496,314173,576142,036Jan 17 07:02 PM
SCHEGERIN MARCCFO and COOJan 16 '24Sale27.496,041166,07137,460Jan 17 07:03 PM
Farrell Robert E JrSVP Finance and CAOJan 16 '24Sale27.495,089139,90034,992Jan 17 07:01 PM
HRTX - Heron Therapeutics Inc - Stock Price Chart
TickerHRTX [NASD, RUT]
CompanyHeron Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap485.09MEPS (ttm)-0.62
P/E-EPS this Y86.11%
Forward P/E329.24EPS next Y108.80%
PEG-EPS past 5Y20.01%
P/S3.67EPS next 5Y47.50%
P/B-EPS Q/Q92.39%
Dividend-Sales Q/Q17.07%
Insider Own5.10%Inst Own72.82%
Insider Trans4.20%Inst Trans7.18%
Short Float19.09%EarningsMay 07/b
Analyst Recom1.25Target Price6.75
Avg Volume2.30M52W Range0.50 - 3.22
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Forbes William PEVP, Chief Development OfficerNov 17 '23Buy1.0925,00027,25079,000Nov 21 12:19 PM
Collard Craig AChief Executive OfficerNov 16 '23Buy0.92150,000137,970186,496Nov 17 12:37 PM
Duarte IraEVP, Chief Financial OfficerNov 16 '23Buy0.8985,00075,59985,000Nov 17 12:36 PM
Forbes William PEVP, Chief Development OfficerNov 16 '23Buy0.9450,00046,99554,000Nov 20 10:07 AM
Morgan AdamDirectorJul 21 '23Buy1.372,486,7443,406,8396,986,744Jul 25 04:22 PM
NATL - NCR Atleos Corp - Stock Price Chart
TickerNATL [NYSE]
CompanyNCR Atleos Corp
CountryUSA
IndustrySoftware - Application
Market Cap2.04BEPS (ttm)-2.46
P/E-EPS this Y267.93%
Forward P/E5.92EPS next Y55.02%
PEG-EPS past 5Y-
P/S0.48EPS next 5Y-
P/B7.22EPS Q/Q-121.91%
Dividend-Sales Q/Q6.49%
Insider Own2.51%Inst Own89.70%
Insider Trans-0.00%Inst Trans-
Short Float3.94%EarningsMay 13/a
Analyst Recom1.67Target Price34.67
Avg Volume661.17K52W Range18.00 - 26.50
NCR Atleos Corp. engages in the provision of custom computer programming services. It operates under the following segments: Self-Service Banking, Payment and Network, and Telecommunications and Technology Segments. The Self-Service Banking segment includes financial solutions such as ATM hardware and software, installation, maintenance, and managed and professional services. The Payment and Network segment offers a network of ATMs and multi-functioning financial services kiosks. The Telecommunications and Technology Segment covers managed network and infrastructure services to enterprise clients. The company was founded in 2023 and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DuVall Andrew RChief Accounting OfficerFeb 23 '24Option Exercise0.001,591016,174Feb 27 06:04 PM
OLIVER TIMOTHY CHARLESPresident & CEOFeb 23 '24Option Exercise0.0045,4440254,577Feb 27 05:14 PM
Campbell Paul J.Chief Financial OfficerDec 21 '23Option Exercise0.009,171019,478Dec 26 06:09 PM
DuVall Andrew RVice PresidentDec 21 '23Option Exercise0.005,070010,565Dec 26 06:09 PM
DuVall Andrew RVice PresidentDec 07 '23Sale22.00831,8265,495Dec 11 09:08 PM
GTBP - GT Biopharma Inc - Stock Price Chart
TickerGTBP [NASD]
CompanyGT Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap4.51MEPS (ttm)-7.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y70.75%
P/S-EPS next 5Y-
P/B0.85EPS Q/Q-841.65%
Dividend-Sales Q/Q-
Insider Own10.42%Inst Own89.98%
Insider Trans0.00%Inst Trans-86.53%
Short Float0.48%EarningsMay 15/a
Analyst Recom1.00Target Price150.00
Avg Volume11.14K52W Range2.95 - 16.11
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). Its product, GTB-3550, is initially developed for the treatment of AML and MDS, and other CD33+ hematologic cancers. GT Biopharma has worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology. The company was founded in 1965 and is headquartered in Brisbane, CA.
BW - Babcock & Wilcox Enterprises Inc - Stock Price Chart
TickerBW [NYSE, RUT]
CompanyBabcock & Wilcox Enterprises Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap109.21MEPS (ttm)-2.43
P/E-EPS this Y99.76%
Forward P/E4.85EPS next Y10000.00%
PEG-EPS past 5Y46.93%
P/S0.11EPS next 5Y6.99%
P/B-EPS Q/Q-25.67%
Dividend-Sales Q/Q-19.32%
Insider Own5.79%Inst Own79.99%
Insider Trans1.33%Inst Trans5.78%
Short Float5.62%EarningsMay 09/a
Analyst Recom1.50Target Price4.50
Avg Volume1.62M52W Range0.75 - 6.64
Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morgan Jimmy BChief Operating OfficerMay 02 '24Option Exercise1.0549,01051,460518,717May 03 04:33 PM
Moeller Philip DDirectorMar 21 '24Buy1.1020,00022,00085,774Mar 22 08:04 AM
Young Kenneth MChief Executive OfficerMar 20 '24Buy1.0329,22930,001241,745Mar 22 08:00 AM
Salamone Louis JrChief Financial OfficerMar 20 '24Buy1.024,0004,080636,711Mar 22 08:01 AM
Tato Joseph ADirectorMar 18 '24Buy0.976,0005,81167,303Mar 20 04:32 PM
CDZI - Cadiz Inc. - Stock Price Chart
TickerCDZI [NASD, RUT]
CompanyCadiz Inc.
CountryUSA
IndustryUtilities - Regulated Water
Market Cap203.37MEPS (ttm)-0.49
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.65%
P/S68.24EPS next 5Y-
P/B5.51EPS Q/Q36.56%
Dividend-Sales Q/Q762.31%
Insider Own41.18%Inst Own32.57%
Insider Trans0.11%Inst Trans27.75%
Short Float12.88%Earnings-
Analyst Recom1.00Target Price15.00
Avg Volume200.21K52W Range2.12 - 5.80
Cadiz, Inc. is a land and water resource development company, which engages in the acquisition and development of land with water resources for various uses such as groundwater supply, groundwater storage, and agriculture. The firm's project includes the Cadiz Valley Water Conservation, Recovery and Storage. The company was founded by Keith Brackpool in 1983 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kennedy Susan PCEOApr 18 '24Buy2.2525,00056,250966,921Apr 19 09:47 AM
Kennedy Susan PCEOJan 04 '24Buy2.816,76218,99991,921Jan 04 02:22 PM
Hickox Winston HDirectorSep 25 '23Buy3.303,0309,999176,685Sep 27 07:25 PM
Kennedy Susan PExecutive DirectorSep 21 '23Buy3.1715,82250,15685,159Sep 21 12:49 PM
Dreyfus Maria S.DirectorJul 13 '23Buy3.50100,000350,000110,791Jul 17 08:54 AM
LINK - Interlink Electronics - Stock Price Chart
TickerLINK [NASD]
CompanyInterlink Electronics
CountryUSA
IndustryElectronic Components
Market Cap47.53MEPS (ttm)-0.12
P/E-EPS this Y-556.25%
Forward P/E-EPS next Y17.14%
PEG-EPS past 5Y-
P/S3.45EPS next 5Y-
P/B3.94EPS Q/Q-190.14%
Dividend-Sales Q/Q-4.70%
Insider Own98.48%Inst Own0.68%
Insider Trans0.00%Inst Trans11.29%
Short Float7.31%EarningsMay 09/b
Analyst Recom1.00Target Price7.00
Avg Volume7.76K52W Range4.25 - 11.49
Interlink Electronics, Inc. engages in the design, development, manufacture, and sale of force sensing technology solutions. Its products include force sensing, position sensing and mouse pointing & touchpad. The company was founded on February 27, 1985 and is headquartered in Irvine, CA.
18910111213141516171820